Sagimet Biosciences's total assets is $110M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Sagimet Biosciences (SGMT) currently reports a total assets of $110M as of March 2026. That compares with $150M in the prior-year period — down 26.3% year over year. Use the charts on this page to explore Sagimet Biosciences's total assets history and peer comparisons.
Sagimet Biosciences's total assets decreased from $150M to $110M — a 26.3% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Sagimet Biosciences reported $110M in total assets as of March 2026. That compares with $150M in the prior-year period — down 26.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total assets of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sagimet Biosciences, and consider following SGMT for alerts when major investors trade the stock.